Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Revenue Performance
Above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$266.96M
↑ 26% above average
Average (9y)
$211.70M
Historical baseline
Range
High:$475.82M
Low:$1.56M
CAGR
+27.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $266.96M | +3.8% |
| 2023 | $257.24M | +21.9% |
| 2022 | $211.04M | -35.4% |
| 2021 | $326.55M | -31.4% |
| 2020 | $475.82M | +33.6% |
| 2019 | $356.07M | +22783.7% |
| 2018 | $1.56M | 0.0% |
| 2017 | $1.56M | -99.2% |
| 2016 | $190.11M | +532.8% |
| 2015 | $30.04M | - |